Evaluation of photodynamic therapy and nuclear imaging potential of subphthalocyanine integrated TiO 2 nanoparticles in mammary and cervical tumor cells
dc.contributor.author | Yurt, Fatma | |
dc.contributor.author | Ocakoglu, Kasim | |
dc.contributor.author | Er, Ozge | |
dc.contributor.author | Soylu, Hale Melis | |
dc.contributor.author | Ince, Mine | |
dc.contributor.author | Avci, Clglr Biray | |
dc.contributor.author | Kurt, Cansu Caliskan | |
dc.date.accessioned | 2025-03-17T12:22:52Z | |
dc.date.available | 2025-03-17T12:22:52Z | |
dc.date.issued | 2019 | |
dc.department | Tarsus Üniversitesi | |
dc.description.abstract | This study, subphthalocyanines (SubPc) and SubPc integrated TiO2 nanoparticles (SubPc-TiO2) were synthesized as novel photosensitizers. Their PDT effects were evaluated. Furthermore, nuclear imaging potential of 131I-labelled SubPc/SubPc-TiO2 were examined in mouse mammary carcinoma (EMT6) and cervix adenocarcinoma (HeLa) cell lines. The uptake results show that SubPc labelled with 131I radionuclide (131I-SubPc) in EMT6 and HeLa cell lines was found to be approximately the same as in the WI38 cell line. However, the uptake values of SubPc-TiO2 labelled with 131I (131I-SubPc-TiO2) in EMT6 and HeLa cell lines were determined to be two times higher than in the WI38 cell line. In other words, the target/non-target tissue ratio was identified as two in the EMT6 and HeLa cell lines. 131I-SubPc-TiO2 is promising for imaging or treatment of breast and cervix tumors. In vitro photodynamic therapy studies have shown that SubPc and SubPc-TiO2 are suitable agents for PDT. In addition, SubPc-TiO2 has higher phototoxicity than SubPc. As a future study, in vivo experiments will be held and performed in tumor-bearing nude mice. © 2019 World Scientific Publishing Company. | |
dc.description.sponsorship | TUBITAK, (114Z430) | |
dc.description.sponsorship | Türkiye Bilimsel ve Teknolojik Araştirma Kurumu, TÜBITAK | |
dc.identifier.doi | 10.1142/S1088424619500639-2 | |
dc.identifier.endpage | 915 | |
dc.identifier.issn | 1088-4246 | |
dc.identifier.issue | 7-8 | |
dc.identifier.scopus | 2-s2.0-85067170832 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 908 | |
dc.identifier.uri | https://doi.org/10.1142/S1088424619500639-2 | |
dc.identifier.uri | https://hdl.handle.net/20.500.13099/1427 | |
dc.identifier.volume | 23 | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | |
dc.publisher | World Scientific Publishing Co. Pte Ltd | |
dc.relation.ispartof | Journal of Porphyrins and Phthalocyanines | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_Scopus_20250316 | |
dc.subject | nuclear imaging | |
dc.subject | photodynamic therapy | |
dc.subject | subphthalocyanine | |
dc.subject | titanium nanoparticle | |
dc.title | Evaluation of photodynamic therapy and nuclear imaging potential of subphthalocyanine integrated TiO 2 nanoparticles in mammary and cervical tumor cells | |
dc.type | Article |